IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced updated clinical data from three ongoing studies evaluating darovasertib in metastatic and ...
Kidney-paired donation effectively expands the living donor pool and provides a vital alternative for patients with end-stage ...
Nearly half of India's breast cancer patients are under 50. From painless lumps to subtle breast changes, here are the ...
A new counterfactual machine learning framework estimates how alternative acute nursing care strategies would individually ...
Aids on a gaping wound, and we’re going to keep hearing from the providers that they cannot afford to cover this care,” a ...
A new U.S. News & World Report survey of 1,251 GLP-1 patients reveals that while consumers shop for medical screenings and ...
It might seem strange for a radiation oncologist to help patients avoid her specialty but a doctor at MUSC is helping ...
A survey of 400 cancer patients and caregivers finds that although 75 percent know about generative AI tools, only 24 percent ...
Expansion of nebaprubart (JJP-1212) into RA follows positive interim data from its ongoing Phase 1b trial in linear IgA dermatosis (LAD), marking the second indication for the Company’s lead asset and ...
Patients with autoimmune rheumatic disease who received an updated or booster COVID-19 vaccine demonstrated lower odds of ...
Each October, the Yolanda G. Barco Oncology Institute is awash in pink. From pink Hershey’s kisses to pink scrubs, pink ...
The Lowndes County Sheriff’s Office and Community Benefit Committee are bringing back Horror at the Fairgrounds, a haunted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results